Unlocking the Potential of LRRC8B: A novel Protein Target for Therapeutic Intervention

Target Name: LRRC8B

NCBI ID: G23507

LRRC8B

Unlocking the Potential of LRRC8B: A novel Protein Target for Therapeutic Intervention

Introduction

The protein domain of LRRC8B, also known as Leucine-rich repeat-containing protein 8B, has been identified as a promising drug target and a biomarker for various diseases. LRRC8B is a member of the superfamily of leucine-rich repeat (LRR) proteins, which are characterized by a unique repetitive sequence (1-30 amino acids of leucine repeated unit). As a result of its unique structure and the presence of this repetitive unit, LRRC8B has been shown to play a critical role in various cellular processes, including cell signaling, DNA replication, and protein-protein interactions.

Disease-relevant functions of LRRC8B

The discovery of LRRC8B as a potential drug target and biomarker has significant implications for the treatment of various diseases. LRRC8B has been shown to be involved in several key biological processes that are often disrupted in diseases, including:

1. Cell signaling and signaling pathways

LRRC8B is involved in various signaling pathways that regulate cell behavior, such as cell proliferation, apoptosis, and autophagy. Studies have shown that LRRC8B can interact with various signaling molecules, including TGF-β, NF-kappa-B, and PI3K, to modulate their activity. LRRC8B has also been shown to play a critical role in the regulation of cell adhesion, a process that is often disrupted in diseases such as cancer and neurodegenerative disorders.

1. DNA replication and repair

LRRC8B is involved in the regulation of DNA replication and repair, which are critical processes for maintaining cellular genetic stability. Studies have shown that LRRC8B can interact with the DNA replication machinery to ensure accurate and reliable replication of genetic information. LRRC8B has also has been shown to play a critical role in the regulation of DNA repair, which is often impaired in diseases such as cancer.

1. Protein-protein interactions

LRRC8B is involved in protein-protein interactions, which are critical for the regulation of cellular processes and for the development of diseases. Studies have shown that LRRC8B can interact with various proteins, including its own partner proteins, to regulate their activity and function (7 ). LRRC8B has also been shown to play a critical role in the regulation of protein-protein interactions in the context of various diseases, including cancer.

1. Cellular stress response

LRRC8B is involved in the cellular stress response, which is critical for maintaining cellular homeostasis and for the regulation of cellular processes that are often disrupted in diseases. Studies have shown that LRRC8B can interact with various stress response molecules, including heat shock factors, to regulate their activity and function. LRRC8B has also been shown to play a critical role in the regulation of cellular stress response in diseases such as neurodegenerative disorders.

The potential therapeutic applications of LRRC8B

The identification of LRRC8B as a potential drug target and biomarker has significant implications for the treatment of various diseases. The following are some of the potential therapeutic applications of LRRC8B:

1.Cancer

LRRC8B has been shown to play a critical role in the regulation of cell proliferation and the development of cancer. Therefore, LRRC8B could be an attractive target for cancer therapies that target cell proliferation or apoptosis.

1. Neurodegenerative disorders

LRRC8B has been shown to play a critical role in the regulation of cellular processes that are often disrupted in neurodegenerative disorders. Therefore, LRRC8B could be an attractive target

Protein Name: Leucine Rich Repeat Containing 8 VRAC Subunit B

Functions: Non-essential component of the volume-regulated anion channel (VRAC, also named VSOAC channel), an anion channel required to maintain a constant cell volume in response to extracellular or intracellular osmotic changes (PubMed:24790029, PubMed:26824658, PubMed:28193731). The VRAC channel conducts iodide better than chloride and can also conduct organic osmolytes like taurine. Channel activity requires LRRC8A plus at least one other family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E); channel characteristics depend on the precise subunit composition (PubMed:24790029, PubMed:26824658, PubMed:28193731)

The "LRRC8B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC8B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets